Ayberk Çakır
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ayberk Çakır has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
- Özge Yücel Çelik
Department of Molecular Biology and Genetics, Faculty of Science and Letters, Istanbul Kultur University, Ataköy, Istanbul, Turkey
3 shared publications - Ahmet Kurt
Department of Obstetrics and Gynecology, Ankara Etlik City Hospital, Ankara, Turkey
2 shared publications - Aşkın Evren Güler
Department of Gynecology and Obstetrics, Aşkın Evren Güler Medical Clinic, Ankara 06560, Turkey
2 shared publications - Dilara Sarıkaya Kurt
Department of Obstetrics and Gynecology, Etlik City Hospital, Ankara 06170, Türkiye
2 shared publications - Dilek Sahin
Perinatology Department Ankara Bilkent City Hospital Ankara Turkey
2 shared publications - Nazan Vanlı Tonyalı
Department of Perinatology Ankara Etlik City Hospital Ankara Turkey
2 shared publications
Latest Publications
- Open Access
- 30 September 2026
- Published by Cukurova Anestezi ve Cerrahi Bilimler Dergisi in Cukurova Anestezi ve Cerrahi Bilimler Dergisi
- Vol. 9 (3) , 951-963
Systemic Inflammatory and Immunonutritional Indices for Discriminating Ruptured From Non-Ruptured Endometriomas: A Retrospective Study
Objective: Ruptured endometrioma is an uncommon but clinically important emergency that often mimics other causes of acute abdomen, making timely diagnosis challenging. This study aimed to assess whether inflammatory and immunonutritional indices measured at presentation could discriminate ruptured from non-ruptured endometriomas before surgery.Methods: This retrospective cohort study included 77 women diagnosed with endometrioma between January 2020 and June 2026. Demographic characteristics, laboratory findings, surgical data, and inflammatory indices, including NLR, PLR, SII, SIRI, AISI, dNLR, NPAR, ACR, PNI, HALP, and CLR, were analyzed. Patients were compared according to disease laterality and rupture status. Logistic regression and receiver operating characteristic (ROC) curve analyses were performed to evaluate diagnostic performance.Results: Among the included patients, 57 (74.0%) had unilateral and 20 (26.0%) had bilateral endometriomas. Seven patients (9.1%) experienced spontaneous rupture. No significant differences were observed between unilateral and bilateral disease regarding demographic features, cyst size, hematological parameters, or inflammatory indices. In contrast, patients with ruptured endometriomas had significantly higher SII, SIRI, NLR, NPAR, AISI, and dNLR values than those without rupture. SIRI (AUC 0.865), AISI (AUC 0.861), and dNLR (AUC 0.861) demonstrated the highest diagnostic performance for discriminating of rupture, whereas albumin-based indices, including PNI and ACR, showed limited discriminatory ability.Conclusions: Routine blood count-derived inflammatory indices, particularly SIRI, AISI, and dNLR, may serve as simple, inexpensive, and widely available adjunctive biomarkers for identifying patients at increased risk of endometrioma rupture before surgery. Although these findings require external validation in larger prospective cohorts, they suggest that systemic inflammatory profiling may improve preoperative risk stratification in women presenting with endometrioma.
- 30 September 2026
- Published by Cukurova Anestezi ve Cerrahi Bilimler Dergisi in Cukurova Anestezi ve Cerrahi Bilimler Dergisi
- Vol. 9 (3) , 951-963
Open AccessSystemic Inflammatory and Immunonutritional Indices for Discriminating Ruptured From Non-Ruptured Endometriomas: A Retrospective Study
Objective: Ruptured endometrioma is an uncommon but clinically important emergency that often mimics other causes of acute abdomen, making timely diagnosis challenging. This study aimed to assess whether inflammatory and immunonutritional indices measured at presentation could discriminate ruptured from non-ruptured endometriomas before surgery.Methods: This retrospective cohort study included 77 women diagnosed with endometrioma between January 2020 and June 2026. Demographic characteristics, laboratory findings, surgical data, and inflammatory indices, including NLR, PLR, SII, SIRI, AISI, dNLR, NPAR, ACR, PNI, HALP, and CLR, were analyzed. Patients were compared according to disease laterality and rupture status. Logistic regression and receiver operating characteristic (ROC) curve analyses were performed to evaluate diagnostic performance.Results: Among the included patients, 57 (74.0%) had unilateral and 20 (26.0%) had bilateral endometriomas. Seven patients (9.1%) experienced spontaneous rupture. No significant differences were observed between unilateral and bilateral disease regarding demographic features, cyst size, hematological parameters, or inflammatory indices. In contrast, patients with ruptured endometriomas had significantly higher SII, SIRI, NLR, NPAR, AISI, and dNLR values than those without rupture. SIRI (AUC 0.865), AISI (AUC 0.861), and dNLR (AUC 0.861) demonstrated the highest diagnostic performance for discriminating of rupture, whereas albumin-based indices, including PNI and ACR, showed limited discriminatory ability.Conclusions: Routine blood count-derived inflammatory indices, particularly SIRI, AISI, and dNLR, may serve as simple, inexpensive, and widely available adjunctive biomarkers for identifying patients at increased risk of endometrioma rupture before surgery. Although these findings require external validation in larger prospective cohorts, they suggest that systemic inflammatory profiling may improve preoperative risk stratification in women presenting with endometrioma.
- Open Access
- 8 May 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (19) , e48597
Maternal nutritional depletion and inflammatory stress in late-onset fetal growth restriction: Rethinking hemogram-derived indices for clinical dietary counseling
Fetal growth restriction (FGR) is a multifactorial condition involving placental dysfunction and maternal systemic stress. While diagnosis depends on biometry and Doppler ultrasound, maternal nutritional depletion and inflammation may provide complementary clinical insight after diagnosis. To evaluate maternal nutritional (prognostic nutritional index [PNI], hemoglobin-albumin-lymphocyte-platelet [HALP]) and inflammatory (SII, AISI, SIRI) index differences in pregnancies with late-onset FGR, and explore whether these systemic markers are further altered in the presence of Doppler abnormalities. We conducted a retrospective cohort analysis of anonymized pregnancies followed at Acibadem Atakent Hospital and a private obstetrics clinic in Ankara, Turkey. Women with abdominal circumference and/or estimated fetal weight < 3rd percentile between 34 to 37 weeks were included as late-onset FGR. Two FGR subgroups were defined based on Doppler status (normal vs abnormal uterine, umbilical, or middle cerebral artery Doppler). Controls consisted of healthy singleton pregnancies with normal biometry (>10th percentile) and third-trimester hemogram/biochemical tests. Maternal indices were calculated from routine complete blood count and albumin values, and their association with Doppler abnormalities was assessed using univariate and multinomial logistic regression models. Normality was tested using Kolmogorov–Smirnov; group comparisons used ANOVA or Kruskal–Wallis and χ 2 tests. FGR pregnancies showed marked maternal systemic shifts. Nutritional indices (PNI, HALP) progressively declined from controls to Doppler-normal and Doppler-abnormal FGR, indicating maternal protein reserve depletion. Inflammatory indices (SII, AISI, SIRI) were higher in FGR and further increased in Doppler-abnormal cases, suggesting a maternal inflammatory-dominant stress response that may mirror uteroplacental vascular resistance. These markers did not demonstrate value for FGR prediction prior to clinical diagnosis, but highlight maternal systemic status once FGR is established. Maternal nutritional and inflammatory indices are not diagnostic or predictive tools for FGR, but may support individualized, sustainable nutritional counseling and protein-focused dietary planning after FGR diagnosis. Prospective studies with quantitative dietary assessment are needed to validate mechanistic links and clinical impact.
- 8 May 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (19) , e48597
Open AccessMaternal nutritional depletion and inflammatory stress in late-onset fetal growth restriction: Rethinking hemogram-derived indices for clinical dietary counseling
Fetal growth restriction (FGR) is a multifactorial condition involving placental dysfunction and maternal systemic stress. While diagnosis depends on biometry and Doppler ultrasound, maternal nutritional depletion and inflammation may provide complementary clinical insight after diagnosis. To evaluate maternal nutritional (prognostic nutritional index [PNI], hemoglobin-albumin-lymphocyte-platelet [HALP]) and inflammatory (SII, AISI, SIRI) index differences in pregnancies with late-onset FGR, and explore whether these systemic markers are further altered in the presence of Doppler abnormalities. We conducted a retrospective cohort analysis of anonymized pregnancies followed at Acibadem Atakent Hospital and a private obstetrics clinic in Ankara, Turkey. Women with abdominal circumference and/or estimated fetal weight < 3rd percentile between 34 to 37 weeks were included as late-onset FGR. Two FGR subgroups were defined based on Doppler status (normal vs abnormal uterine, umbilical, or middle cerebral artery Doppler). Controls consisted of healthy singleton pregnancies with normal biometry (>10th percentile) and third-trimester hemogram/biochemical tests. Maternal indices were calculated from routine complete blood count and albumin values, and their association with Doppler abnormalities was assessed using univariate and multinomial logistic regression models. Normality was tested using Kolmogorov–Smirnov; group comparisons used ANOVA or Kruskal–Wallis and χ 2 tests. FGR pregnancies showed marked maternal systemic shifts. Nutritional indices (PNI, HALP) progressively declined from controls to Doppler-normal and Doppler-abnormal FGR, indicating maternal protein reserve depletion. Inflammatory indices (SII, AISI, SIRI) were higher in FGR and further increased in Doppler-abnormal cases, suggesting a maternal inflammatory-dominant stress response that may mirror uteroplacental vascular resistance. These markers did not demonstrate value for FGR prediction prior to clinical diagnosis, but highlight maternal systemic status once FGR is established. Maternal nutritional and inflammatory indices are not diagnostic or predictive tools for FGR, but may support individualized, sustainable nutritional counseling and protein-focused dietary planning after FGR diagnosis. Prospective studies with quantitative dietary assessment are needed to validate mechanistic links and clinical impact.
- Open Access
- 4 May 2026
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 26 (1)
Assessment of albumin-related inflammatory indices in preeclampsia and their relationship with composite adverse perinatal outcomes
Background: Preeclampsia is characterized by systemic inflammation, endothelial dysfunction, and multi-organ involvement, contributing to increased risk of adverse perinatal outcomes. Albumin-based inflammatory and nutritional indices have recently gained interest as easily accessible biomarkers in high-risk pregnancies. This study aimed to compare albumin-related indices between preeclamptic and normotensive pregnancies and to evaluate their predictive value for composite adverse perinatal outcomes (CAPO) in preeclampsia. Methods: This retrospective case–control study included 186 preeclamptic patients and 186 healthy controls matched for maternal age, BMI, gravidity, and gestational age. Laboratory parameters measured at delivery and calculated indices (NAR, FAR, sACR, HALP, and BAR) were compared. The preeclampsia cohort was further classified into CAPO (+) and CAPO (–) groups. Logistic regression models were used to identify independent predictors of CAPO, and receiver operating characteristic (ROC) analysis assessed predictive performance. Results: Albumin-based indices differed significantly between preeclamptic and healthy pregnancies, with higher NAR, FAR, and BAR values and lower sACR levels in the preeclampsia group (all p < 0.001). Among preeclamptic patients, CAPO developed in 44.1% ( n = 82). CAPO (+) patients demonstrated higher NAR, BAR, and HALP values and lower sACR levels compared to CAPO (–) patients. In multivariable logistic regression, only the blood urea nitrogen-to-albumin ratio (BAR) remained independently associated with CAPO (aOR = 1.157, p = 0.015). BAR demonstrated moderate discriminative performance for CAPO (AUC = 0.718; cut-off > 0.61; sensitivity 67.1%; specificity 69.2%; p < 0.001). Conclusion: All albumin-based indices showed significant alterations in preeclampsia; however, only BAR independently predicted adverse perinatal outcomes. BAR is a simple, inexpensive biomarker derived from routine laboratory parameters and may support risk stratification and neonatal outcome prediction in preeclamptic pregnancies. Prospective multicenter studies are warranted to validate its clinical applicability.
- 4 May 2026
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 26 (1)
Open AccessAssessment of albumin-related inflammatory indices in preeclampsia and their relationship with composite adverse perinatal outcomes
Background: Preeclampsia is characterized by systemic inflammation, endothelial dysfunction, and multi-organ involvement, contributing to increased risk of adverse perinatal outcomes. Albumin-based inflammatory and nutritional indices have recently gained interest as easily accessible biomarkers in high-risk pregnancies. This study aimed to compare albumin-related indices between preeclamptic and normotensive pregnancies and to evaluate their predictive value for composite adverse perinatal outcomes (CAPO) in preeclampsia. Methods: This retrospective case–control study included 186 preeclamptic patients and 186 healthy controls matched for maternal age, BMI, gravidity, and gestational age. Laboratory parameters measured at delivery and calculated indices (NAR, FAR, sACR, HALP, and BAR) were compared. The preeclampsia cohort was further classified into CAPO (+) and CAPO (–) groups. Logistic regression models were used to identify independent predictors of CAPO, and receiver operating characteristic (ROC) analysis assessed predictive performance. Results: Albumin-based indices differed significantly between preeclamptic and healthy pregnancies, with higher NAR, FAR, and BAR values and lower sACR levels in the preeclampsia group (all p < 0.001). Among preeclamptic patients, CAPO developed in 44.1% ( n = 82). CAPO (+) patients demonstrated higher NAR, BAR, and HALP values and lower sACR levels compared to CAPO (–) patients. In multivariable logistic regression, only the blood urea nitrogen-to-albumin ratio (BAR) remained independently associated with CAPO (aOR = 1.157, p = 0.015). BAR demonstrated moderate discriminative performance for CAPO (AUC = 0.718; cut-off > 0.61; sensitivity 67.1%; specificity 69.2%; p < 0.001). Conclusion: All albumin-based indices showed significant alterations in preeclampsia; however, only BAR independently predicted adverse perinatal outcomes. BAR is a simple, inexpensive biomarker derived from routine laboratory parameters and may support risk stratification and neonatal outcome prediction in preeclamptic pregnancies. Prospective multicenter studies are warranted to validate its clinical applicability.
- Open Access
- 8 January 2026
- Published by Acibadem Universitesi Saglik Bilimleri Dergisi in Acibadem Universitesi Saglik Bilimleri Dergisi
- Vol. 17 (January, F)
Obstetric and Neonatal Outcomes of Twin Pregnancies Following Double Embryo Transfer on Day 3 versus Day 5
Background: Multiple pregnancies following assisted reproductive technologies (ART) remain a major contributor to perinatal morbidity and mortality. While the impact of embryo transfer day —cleavage-stage (day 3) versus blastocyststage (day 5)— has been extensively studied in singleton pregnancies, data focusing specifically on twin pregnancies resulting from double embryo transfer (DET) are limited. This study aimed to compare obstetric and neonatal outcomes of twin pregnancies following DET on day 3 (D3) versus day 5 (D5).Methods: This retrospective single-centre cohort study included fresh ART cycles performed between 2010-2022. A total of 47 liveborn twin pregnancies following DET were analysed (D3: n = 28; D5: n = 19). Maternal demographic and clinical characteristics were recorded. Primary outcomes included gestational age at birth, birthweight, and composite adverse perinatal outcome (CAPO). Secondary outcomes included neonatal morbidities such as NICU admission, respiratory distress syndrome, sepsis, and neonatal mortality.Results: Maternal baseline characteristics were comparable between groups. Gestational age at birth and birthweight did not differ significantly between D3 and D5 transfers (p >0.05). The incidence of CAPO was similar in both groups (35.7% vs 39.5%, p=0.711). Rates of NICU admission, Apgar score ≤ 7 at 5 minutes, respiratory distress syndrome, and neonatal mortality were also comparable.Conclusions: The day of double embryo transfer (D3 vs D5) was not associated with obstetric or neonatal outcomes in twin pregnancies. These findings suggest that limiting embryo number and appropriate patient selection are more critical than transfer day in reducing risks related to multiple pregnancies.
- 8 January 2026
- Published by Acibadem Universitesi Saglik Bilimleri Dergisi in Acibadem Universitesi Saglik Bilimleri Dergisi
- Vol. 17 (January, F)
Open AccessObstetric and Neonatal Outcomes of Twin Pregnancies Following Double Embryo Transfer on Day 3 versus Day 5
Background: Multiple pregnancies following assisted reproductive technologies (ART) remain a major contributor to perinatal morbidity and mortality. While the impact of embryo transfer day —cleavage-stage (day 3) versus blastocyststage (day 5)— has been extensively studied in singleton pregnancies, data focusing specifically on twin pregnancies resulting from double embryo transfer (DET) are limited. This study aimed to compare obstetric and neonatal outcomes of twin pregnancies following DET on day 3 (D3) versus day 5 (D5).Methods: This retrospective single-centre cohort study included fresh ART cycles performed between 2010-2022. A total of 47 liveborn twin pregnancies following DET were analysed (D3: n = 28; D5: n = 19). Maternal demographic and clinical characteristics were recorded. Primary outcomes included gestational age at birth, birthweight, and composite adverse perinatal outcome (CAPO). Secondary outcomes included neonatal morbidities such as NICU admission, respiratory distress syndrome, sepsis, and neonatal mortality.Results: Maternal baseline characteristics were comparable between groups. Gestational age at birth and birthweight did not differ significantly between D3 and D5 transfers (p >0.05). The incidence of CAPO was similar in both groups (35.7% vs 39.5%, p=0.711). Rates of NICU admission, Apgar score ≤ 7 at 5 minutes, respiratory distress syndrome, and neonatal mortality were also comparable.Conclusions: The day of double embryo transfer (D3 vs D5) was not associated with obstetric or neonatal outcomes in twin pregnancies. These findings suggest that limiting embryo number and appropriate patient selection are more critical than transfer day in reducing risks related to multiple pregnancies.
- Open Access
- 1 January 2026
- Published by Walter de Gruyter GmbH in Case Reports in Perinatal Medicine
- Vol. 15 (1)
Fetal ductus arteriosus constriction following maternal analgesic exposure
Objectives: Premature constriction of the fetal ductus arteriosus is a clinically relevant cause of fetal cardiac compromise. Maternal exposure to prostaglandin-inhibiting analgesics is a recognized trigger. We describe two pregnancies complicated by fetal ductus arteriosus constriction temporally associated with maternal analgesic use. Case presentation: In the first case, ductal constriction occurred after a seven-day course of indomethacin initiated at 28 weeks’ gestation for polyhydramnios. Although initial improvement followed drug discontinuation, recurrent constriction with right ventricular dilation, severe tricuspid regurgitation, ductus venosus A-wave reversal, and a non-reactive fetal heart rate tracing indicated progressive hemodynamic compromise, prompting preterm delivery at 31+6 weeks. Postnatal echocardiography showed normalization of right ventricular function. In the second case, ductal constriction with right ventricular dilation and tricuspid regurgitation was detected at 38+5 weeks after frequent third-trimester use of a paracetamol-containing analgesic. Delivery at 39 weeks was performed primarily for prior uterine surgery, and postnatal evaluation confirmed normal pulmonary pressures and right ventricular function. Conclusions: Maternal exposure to prostaglandin-inhibiting analgesics should be considered in cases of fetal ductus arteriosus constriction. Careful medication history and targeted fetal echocardiography are essential for timely diagnosis and appropriate perinatal management.
- 1 January 2026
- Published by Walter de Gruyter GmbH in Case Reports in Perinatal Medicine
- Vol. 15 (1)
Open AccessFetal ductus arteriosus constriction following maternal analgesic exposure
Objectives: Premature constriction of the fetal ductus arteriosus is a clinically relevant cause of fetal cardiac compromise. Maternal exposure to prostaglandin-inhibiting analgesics is a recognized trigger. We describe two pregnancies complicated by fetal ductus arteriosus constriction temporally associated with maternal analgesic use. Case presentation: In the first case, ductal constriction occurred after a seven-day course of indomethacin initiated at 28 weeks’ gestation for polyhydramnios. Although initial improvement followed drug discontinuation, recurrent constriction with right ventricular dilation, severe tricuspid regurgitation, ductus venosus A-wave reversal, and a non-reactive fetal heart rate tracing indicated progressive hemodynamic compromise, prompting preterm delivery at 31+6 weeks. Postnatal echocardiography showed normalization of right ventricular function. In the second case, ductal constriction with right ventricular dilation and tricuspid regurgitation was detected at 38+5 weeks after frequent third-trimester use of a paracetamol-containing analgesic. Delivery at 39 weeks was performed primarily for prior uterine surgery, and postnatal evaluation confirmed normal pulmonary pressures and right ventricular function. Conclusions: Maternal exposure to prostaglandin-inhibiting analgesics should be considered in cases of fetal ductus arteriosus constriction. Careful medication history and targeted fetal echocardiography are essential for timely diagnosis and appropriate perinatal management.
- Open Access
Investigation of the Relationship Between IL-17, IL-27, IL-2 Blood Levels in Spontaneous Abortion and Healthy Pregnant Women
Background: Cytokines are essential for regulating immune cell activity during pregnancy. Research shows that CD4+ T-cells exhibit specific cytokine secretion patterns, resulting in polarized immune responses. This study aims to compare the gene expression levels of Th1, Th2, and Th17 cytokines in women with normal pregnancies versus those with a history of recurrent spontaneous abortion (RSA). Methods: In this case-control study, 20 patients with RSA within 24 h of their last abortion were compared to 20 pregnant women with no history of abortion (Control Group). Cytokine levels of IL-2, IL-17, and IL-27 were quantified using real-time polymerase chain reaction (RT-PCR). Results: Overall cytokine levels were similar between the groups, but the cytokine levels in both groups were generally similar. However, higher IL-17 and IL-2 levels were observed in the healthy pregnancy group (p = 0.006 and p = 0.001, respectively). Elevated IL-17 and IL-27 levels were observed in healthy pregnancies, whereas lower levels were seen shortly after a miscarriage. IL-27 levels were significantly higher in women with recurrent abortions compared to those with healthy pregnancies (p < 0.001). Conclusions: Elevated IL-2 levels may be a risk factor for RSA. Consistent with recent studies, our findings emphasize the role of IL-17 and IL-27 as crucial regulatory cytokines for maintaining a successful pregnancy.
Open AccessInvestigation of the Relationship Between IL-17, IL-27, IL-2 Blood Levels in Spontaneous Abortion and Healthy Pregnant Women
Background: Cytokines are essential for regulating immune cell activity during pregnancy. Research shows that CD4+ T-cells exhibit specific cytokine secretion patterns, resulting in polarized immune responses. This study aims to compare the gene expression levels of Th1, Th2, and Th17 cytokines in women with normal pregnancies versus those with a history of recurrent spontaneous abortion (RSA). Methods: In this case-control study, 20 patients with RSA within 24 h of their last abortion were compared to 20 pregnant women with no history of abortion (Control Group). Cytokine levels of IL-2, IL-17, and IL-27 were quantified using real-time polymerase chain reaction (RT-PCR). Results: Overall cytokine levels were similar between the groups, but the cytokine levels in both groups were generally similar. However, higher IL-17 and IL-2 levels were observed in the healthy pregnancy group (p = 0.006 and p = 0.001, respectively). Elevated IL-17 and IL-27 levels were observed in healthy pregnancies, whereas lower levels were seen shortly after a miscarriage. IL-27 levels were significantly higher in women with recurrent abortions compared to those with healthy pregnancies (p < 0.001). Conclusions: Elevated IL-2 levels may be a risk factor for RSA. Consistent with recent studies, our findings emphasize the role of IL-17 and IL-27 as crucial regulatory cytokines for maintaining a successful pregnancy.
- Open Access
- 7 October 2024
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 24 (1) , 1-8
Delta neutrophil index (DNI) as a potential biomarker for fetal growth restriction: insights from maternal hematological changes and neonatal outcomes
This study investigates the role of Delta Neutrophil Index (DNI), an inflammation marker, in late-onset fetal growth restriction (LO-FGR) and its prediction of composite adverse neonatal outcomes. A retrospective study was conducted on 684 pregnant women (456 with normal fetal development and 228 with LO-FGR) who delivered at Health Sciences University Etlik Zubeyde Hanim Women’s Health Training and Research Hospital between January 1, 2015, and June 30, 2018. Composite adverse neonatal outcomes were defined as at least one of the following: 5th minute APGAR score < 7, respiratory distress syndrome (RDS), or neonatal intensive care unit (NICU) admission. The FGR group had significantly higher levels of neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), monocyte to lymphocyte ratio (MLR), and DNI compared to controls (p < 0.05, for all). For FGR diagnosis, the DNI demonstrated the highest area under the curve (AUC = 0.677, 95% CI: 0.642–0.711) with a cut-off value of > -2.9, yielding a sensitivity of 78.41%, a specificity of 52.97%, a positive likelihood ratio (+ LR) of 1.68, and a negative likelihood ratio (-LR) of 0.37 (p < 0.001). For predicting composite adverse neonatal outcomes in the FGR group, DNI again demonstrated superior performance with an AUC of 0.635 (95% CI: 0.598–0.670), a cut-off value of > -2.2, a sensitivity of 69.90%, a specificity of 55.36%, a + LR of 1.56, and a -LR of 0.51 (p < 0.001). NLR, PLR, and MLR had AUCs below 0.55, indicating poor discriminative ability, with none reaching statistical significance. This study highlights the potential role of DNI as a promising biomarker for detecting inflammatory processes associated with LO-FGR and its complications.
- 7 October 2024
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 24 (1) , 1-8
Open AccessDelta neutrophil index (DNI) as a potential biomarker for fetal growth restriction: insights from maternal hematological changes and neonatal outcomes
This study investigates the role of Delta Neutrophil Index (DNI), an inflammation marker, in late-onset fetal growth restriction (LO-FGR) and its prediction of composite adverse neonatal outcomes. A retrospective study was conducted on 684 pregnant women (456 with normal fetal development and 228 with LO-FGR) who delivered at Health Sciences University Etlik Zubeyde Hanim Women’s Health Training and Research Hospital between January 1, 2015, and June 30, 2018. Composite adverse neonatal outcomes were defined as at least one of the following: 5th minute APGAR score < 7, respiratory distress syndrome (RDS), or neonatal intensive care unit (NICU) admission. The FGR group had significantly higher levels of neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), monocyte to lymphocyte ratio (MLR), and DNI compared to controls (p < 0.05, for all). For FGR diagnosis, the DNI demonstrated the highest area under the curve (AUC = 0.677, 95% CI: 0.642–0.711) with a cut-off value of > -2.9, yielding a sensitivity of 78.41%, a specificity of 52.97%, a positive likelihood ratio (+ LR) of 1.68, and a negative likelihood ratio (-LR) of 0.37 (p < 0.001). For predicting composite adverse neonatal outcomes in the FGR group, DNI again demonstrated superior performance with an AUC of 0.635 (95% CI: 0.598–0.670), a cut-off value of > -2.2, a sensitivity of 69.90%, a specificity of 55.36%, a + LR of 1.56, and a -LR of 0.51 (p < 0.001). NLR, PLR, and MLR had AUCs below 0.55, indicating poor discriminative ability, with none reaching statistical significance. This study highlights the potential role of DNI as a promising biomarker for detecting inflammatory processes associated with LO-FGR and its complications.
- Open Access
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 70 (7) , e20231723
Etiology and perinatal outcomes between early and late-onset nonimmune hydrops fetalis
We aimed to compare the etiology and perinatal outcomes of non-immune hydrops fetalis diagnosed early- and late-onset at our hospital.
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 70 (7) , e20231723
Open AccessEtiology and perinatal outcomes between early and late-onset nonimmune hydrops fetalis
We aimed to compare the etiology and perinatal outcomes of non-immune hydrops fetalis diagnosed early- and late-onset at our hospital.